Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acral lentiginous melanoma

C A Ridgeway1, T J Hieken, S G Ronan

  • 1Department of Surgical Oncology, University of Illinois at Chicago.

Archives of Surgery (Chicago, Ill. : 1960)
|January 1, 1995
PubMed
Summary

Acral lentiginous melanoma (ALM) does not independently impact patient outcomes. Tumor thickness, not histologic subtype, is the key prognostic factor for survival in melanoma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated CSF Beta Trace Protein Levels in Patients with CSF-Venous Fistulas.

AJNR. American journal of neuroradiology·2026
Same author

Expert-involved continuous renal replacement therapy device development: addressing user needs through human factors engineering.

Expert review of medical devices·2025
Same author

Spinal CSF Leaks: The Neuroradiologist Transforming Care.

AJNR. American journal of neuroradiology·2024
Same author

CT-Guided Epidural Contrast Injection for the Identification of Dural Defects.

AJNR. American journal of neuroradiology·2024
Same author

Sacroiliitis in inflammatory bowel disease on abdominal computed tomography: prevalence, misses, and associated factors.

Scandinavian journal of rheumatology·2024
Same author

The clue is in the kidneys: greater renal contrast medium accumulation on ipsilateral side down CT myelogram after lateral decubitus digital subtraction myelogram as a predictor of laterality of cerebrospinal fluid leak.

Clinical radiology·2023

Area of Science:

  • Oncology
  • Dermatopathology
  • Surgical Oncology

Background:

  • Acral lentiginous melanoma (ALM) is a distinct histologic subtype of cutaneous melanoma.
  • ALM often presents in older individuals with diverse ethnic backgrounds and on lower extremities.
  • Previous studies suggested potential differences in prognosis for ALM compared to other melanoma subtypes.

Purpose of the Study:

  • To determine if acral lentiginous melanoma (ALM) has independent prognostic significance.
  • To compare survival outcomes and lymph node metastasis rates among different melanoma histologic subtypes.

Main Methods:

  • Retrospective case series review of 56 patients with histologically confirmed ALM.
  • Analysis included lymph node metastases, disease-free survival, and overall survival.
  • Logistic regression and multifactorial analysis were used, controlling for tumor thickness.

Main Results:

  • No significant difference in lymph node metastasis rates was observed between ALM and other melanoma subtypes.
  • After adjusting for tumor thickness, disease-free and overall survival were similar across histologic groups.
  • Tumor thickness was identified as the sole significant prognostic variable for survival.

Conclusions:

  • The histologic subtype of acral lentiginous melanoma does not confer independent prognostic significance.
  • Patient age, ethnicity, and tumor location characteristics associated with ALM do not independently affect outcomes.
  • Melanoma tumor thickness remains the primary determinant of prognosis, regardless of histologic subtype.

Related Experiment Videos